Literature DB >> 24478569

The Dantzig Selector for Censored Linear Regression Models.

Yi Li1, Lee Dicker2, Sihai Dave Zhao3.   

Abstract

The Dantzig variable selector has recently emerged as a powerful tool for fitting regularized regression models. To our knowledge, most work involving the Dantzig selector has been performed with fully-observed response variables. This paper proposes a new class of adaptive Dantzig variable selectors for linear regression models when the response variable is subject to right censoring. This is motivated by a clinical study to identify genes predictive of event-free survival in newly diagnosed multiple myeloma patients. Under some mild conditions, we establish the theoretical properties of our procedures, including consistency in model selection (i.e. the right subset model will be identified with a probability tending to 1) and the optimal efficiency of estimation (i.e. the asymptotic distribution of the estimates is the same as that when the true subset model is known a priori). The practical utility of the proposed adaptive Dantzig selectors is verified via extensive simulations. We apply our new methods to the aforementioned myeloma clinical trial and identify important predictive genes.

Entities:  

Keywords:  Buckley-James imputation; Censored linear regression; Dantzig selector; Oracle property

Year:  2014        PMID: 24478569      PMCID: PMC3903419          DOI: 10.5705/ss.2011.220

Source DB:  PubMed          Journal:  Stat Sin        ISSN: 1017-0405            Impact factor:   1.261


  19 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  Penalized Estimating Functions and Variable Selection in Semiparametric Regression Models.

Authors:  Brent A Johnson; D Y Lin; Donglin Zeng
Journal:  J Am Stat Assoc       Date:  2008-06-01       Impact factor: 5.033

3.  Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature.

Authors:  E M Anderson; P Miller; D Ilsley; W Marshall; A Khvorova; C A Stein; L Benimetskaya
Journal:  Cancer Gene Ther       Date:  2006-04       Impact factor: 5.987

4.  Additive risk models for survival data with high-dimensional covariates.

Authors:  Shuangge Ma; Michael R Kosorok; Jason P Fine
Journal:  Biometrics       Date:  2006-03       Impact factor: 2.571

5.  Doubly penalized buckley-james method for survival data with high-dimensional covariates.

Authors:  Sijian Wang; Bin Nan; Ji Zhu; David G Beer
Journal:  Biometrics       Date:  2007-08-03       Impact factor: 2.571

6.  On path restoration for censored outcomes.

Authors:  Brent A Johnson; Qi Long; Matthias Chung
Journal:  Biometrics       Date:  2011-04-02       Impact factor: 2.571

7.  The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.

Authors:  Leming Shi; Gregory Campbell; Wendell D Jones; Fabien Campagne; Zhining Wen; Stephen J Walker; Zhenqiang Su; Tzu-Ming Chu; Federico M Goodsaid; Lajos Pusztai; John D Shaughnessy; André Oberthuer; Russell S Thomas; Richard S Paules; Mark Fielden; Bart Barlogie; Weijie Chen; Pan Du; Matthias Fischer; Cesare Furlanello; Brandon D Gallas; Xijin Ge; Dalila B Megherbi; W Fraser Symmans; May D Wang; John Zhang; Hans Bitter; Benedikt Brors; Pierre R Bushel; Max Bylesjo; Minjun Chen; Jie Cheng; Jing Cheng; Jeff Chou; Timothy S Davison; Mauro Delorenzi; Youping Deng; Viswanath Devanarayan; David J Dix; Joaquin Dopazo; Kevin C Dorff; Fathi Elloumi; Jianqing Fan; Shicai Fan; Xiaohui Fan; Hong Fang; Nina Gonzaludo; Kenneth R Hess; Huixiao Hong; Jun Huan; Rafael A Irizarry; Richard Judson; Dilafruz Juraeva; Samir Lababidi; Christophe G Lambert; Li Li; Yanen Li; Zhen Li; Simon M Lin; Guozhen Liu; Edward K Lobenhofer; Jun Luo; Wen Luo; Matthew N McCall; Yuri Nikolsky; Gene A Pennello; Roger G Perkins; Reena Philip; Vlad Popovici; Nathan D Price; Feng Qian; Andreas Scherer; Tieliu Shi; Weiwei Shi; Jaeyun Sung; Danielle Thierry-Mieg; Jean Thierry-Mieg; Venkata Thodima; Johan Trygg; Lakshmi Vishnuvajjala; Sue Jane Wang; Jianping Wu; Yichao Wu; Qian Xie; Waleed A Yousef; Liang Zhang; Xuegong Zhang; Sheng Zhong; Yiming Zhou; Sheng Zhu; Dhivya Arasappan; Wenjun Bao; Anne Bergstrom Lucas; Frank Berthold; Richard J Brennan; Andreas Buness; Jennifer G Catalano; Chang Chang; Rong Chen; Yiyu Cheng; Jian Cui; Wendy Czika; Francesca Demichelis; Xutao Deng; Damir Dosymbekov; Roland Eils; Yang Feng; Jennifer Fostel; Stephanie Fulmer-Smentek; James C Fuscoe; Laurent Gatto; Weigong Ge; Darlene R Goldstein; Li Guo; Donald N Halbert; Jing Han; Stephen C Harris; Christos Hatzis; Damir Herman; Jianping Huang; Roderick V Jensen; Rui Jiang; Charles D Johnson; Giuseppe Jurman; Yvonne Kahlert; Sadik A Khuder; Matthias Kohl; Jianying Li; Li Li; Menglong Li; Quan-Zhen Li; Shao Li; Zhiguang Li; Jie Liu; Ying Liu; Zhichao Liu; Lu Meng; Manuel Madera; Francisco Martinez-Murillo; Ignacio Medina; Joseph Meehan; Kelci Miclaus; Richard A Moffitt; David Montaner; Piali Mukherjee; George J Mulligan; Padraic Neville; Tatiana Nikolskaya; Baitang Ning; Grier P Page; Joel Parker; R Mitchell Parry; Xuejun Peng; Ron L Peterson; John H Phan; Brian Quanz; Yi Ren; Samantha Riccadonna; Alan H Roter; Frank W Samuelson; Martin M Schumacher; Joseph D Shambaugh; Qiang Shi; Richard Shippy; Shengzhu Si; Aaron Smalter; Christos Sotiriou; Mat Soukup; Frank Staedtler; Guido Steiner; Todd H Stokes; Qinglan Sun; Pei-Yi Tan; Rong Tang; Zivana Tezak; Brett Thorn; Marina Tsyganova; Yaron Turpaz; Silvia C Vega; Roberto Visintainer; Juergen von Frese; Charles Wang; Eric Wang; Junwei Wang; Wei Wang; Frank Westermann; James C Willey; Matthew Woods; Shujian Wu; Nianqing Xiao; Joshua Xu; Lei Xu; Lun Yang; Xiao Zeng; Jialu Zhang; Li Zhang; Min Zhang; Chen Zhao; Raj K Puri; Uwe Scherf; Weida Tong; Russell D Wolfinger
Journal:  Nat Biotechnol       Date:  2010-07-30       Impact factor: 54.908

8.  A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

Authors:  John D Shaughnessy; Fenghuang Zhan; Bart E Burington; Yongsheng Huang; Simona Colla; Ichiro Hanamura; James P Stewart; Bob Kordsmeier; Christopher Randolph; David R Williams; Yan Xiao; Hongwei Xu; Joshua Epstein; Elias Anaissie; Somashekar G Krishna; Michele Cottler-Fox; Klaus Hollmig; Abid Mohiuddin; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Jeffrey Sawyer; Yazan Alsayed; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

9.  Kernel Cox regression models for linking gene expression profiles to censored survival data.

Authors:  Hongzhe Li; Yihui Luan
Journal:  Pac Symp Biocomput       Date:  2003

10.  Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Authors:  Yudi Pawitan; Judith Bjöhle; Lukas Amler; Anna-Lena Borg; Suzanne Egyhazi; Per Hall; Xia Han; Lars Holmberg; Fei Huang; Sigrid Klaar; Edison T Liu; Lance Miller; Hans Nordgren; Alexander Ploner; Kerstin Sandelin; Peter M Shaw; Johanna Smeds; Lambert Skoog; Sara Wedrén; Jonas Bergh
Journal:  Breast Cancer Res       Date:  2005-10-03       Impact factor: 6.466

View more
  3 in total

1.  Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.

Authors:  Perrine Soret; Marta Avalos; Linda Wittkop; Daniel Commenges; Rodolphe Thiébaut
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

2.  Optimization of individualized dynamic treatment regimes for recurrent diseases.

Authors:  Xuelin Huang; Jing Ning; Abdus S Wahed
Journal:  Stat Med       Date:  2014-02-09       Impact factor: 2.373

3.  A new joint screening method for right-censored time-to-event data with ultra-high dimensional covariates.

Authors:  Yi Liu; Xiaolin Chen; Gang Li
Journal:  Stat Methods Med Res       Date:  2019-07-30       Impact factor: 2.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.